ROCKET PHARMACEUTICALS, INC.

RCKT US77313F1066

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Annual Performance ¹

2021	2022	2023	2024	2025
-61%	-17%	56%	-57%	-1%

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Bjork Elisabeth	3.41 USD	10,000 Bought	34,100 USD	27/08/2025	27/08/2025
Schwartz Jonathan David O	3.00 USD	805 Sold	2,412 USD	18/08/2025	19/08/2025
Wilson Martin SR OFF	3.00 USD	588 Sold	1,762 USD	18/08/2025	19/08/2025
Militello John O	3.00 USD	361 Sold	1,082 USD	18/08/2025	19/08/2025
Militello John O	3.07 USD	699 Sold	2,142 USD	18/08/2025	18/08/2025
Schwartz Jonathan David O	3.07 USD	1,680 Sold	5,149 USD	18/08/2025	18/08/2025
Wilson Martin SR OFF	3.07 USD	1,004 Sold	3,077 USD	18/08/2025	18/08/2025
Schwartz Jonathan David O	3.02 USD	11,161 Sold	33,695 USD	14/08/2025	14/08/2025
Militello John O	3.02 USD	7,043 Sold	21,263 USD	14/08/2025	14/08/2025
Wilson Martin SR OFF	3.02 USD	12,109 Sold	36,557 USD	14/08/2025	14/08/2025

Load More

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include ROCKET PHARMACEUTICALS, INC. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Historical Performance

1M	3M	6M	1Y	3Y	5Y	All Time
-29%	-49%	-55%	-37%	-49%	208%	-73%

Last	52W Low	52W High	All-Time Low	All-Time High	β
3.18	2.33	8.73	2.33	8.73

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Makker Gotham	2	8,241,589.40	4,120,794.70	15/11/2023	21/03/2024
Southwell David P	3	1,945,784.68	648,594.89	12/04/2024	15/04/2024
Shah Gaurav	10	1,507,225.15	150,722.51	16/02/2024	20/05/2025
Militello John	21	686,906.22	32,709.82	20/10/2023	19/08/2025
Patel Kinnari	10	632,737.53	63,273.75	16/02/2024	20/05/2025
White Mark Andrew	3	421,683.69	140,561.23	08/04/2024	31/10/2024
Wilson Martin	13	381,173.97	29,321.07	16/02/2024	19/08/2025
Schwartz Jonathan David	11	296,202.45	26,927.50	17/05/2024	19/08/2025
Ondrey Aaron	2	43,903.48	21,951.74	04/04/2025	03/07/2025
Bjork Elisabeth	1	34,100.00	34,100.00	27/08/2025	27/08/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
PTC THERAPEUTICS, INC.	US69366J2006	PTCT

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.